Dana-Farber Cancer Institute

Understand the 'Why' Behind Treatment Decisions

Access expert-curated treatment pathways from Dana-Farber Cancer Institute. Go beyond the data to understand the clinical rationale driving oncology treatment recommendations.

Trusted by leading life sciences companies

Partner 1
Partner 2
Partner 3
Partner 4
https://pathways.dfci.harvard.edu/dashboard
Dana-Farber Pathways Dashboard

More Than Just Treatment Data

Dana-Farber Pathways provides unprecedented access to expert clinical reasoning, not just treatment recommendations.

Expert Consensus Pathways

Access treatment protocols developed by Dana-Farber physicians based on the latest clinical evidence and real-world outcomes.

Clinical Rationale

Go beyond the "what" to understand the "why" with documented reasoning from pathway committee discussions.

Provider Analytics

Gain insights into prescribing patterns and how treatments are being used in academic oncology settings.

Platform Capabilities

A comprehensive suite of tools designed for life sciences professionals to access and analyze expert oncology insights.

Pathways Content Explorer

Navigate treatment decision trees with interactive visualizations showing expert consensus protocols.

Drug Search & Placement

Search any drug to see its placement across all pathways, with line of therapy and clinical context.

Meeting Minutes Access

Secure access to pathway committee meeting recordings with AI-generated summaries.

Rationale Documentation

Understand the clinical evidence and expert reasoning behind every treatment recommendation.

Version History

Track how pathways evolve over time with full change history and comparison tools.

Custom Watchlists

Monitor specific drugs and receive notifications when their pathway placement changes.

See the Platform in Action

Explore our intuitive interface designed for life sciences professionals.

Interactive treatment decision trees with expert consensus protocols

https://pathways.dfci.harvard.edu/pathways
Pathway Explorer screenshot

12 Disease Centers

Comprehensive coverage across major oncology therapeutic areas, each with expert-curated treatment pathways.

BOC

Breast Oncology Center

8 Pathways
GI

Gastrointestinal Oncology

6 Pathways
HNO

Head & Neck Oncology

4 Pathways
THO

Thoracic Oncology

7 Pathways
GU

Genitourinary Oncology

5 Pathways
MEL

Melanoma

3 Pathways
GYN

Gynecologic Oncology

4 Pathways
SARC

Sarcoma

2 Pathways
HEM

Hematologic Malignancies

6 Pathways
NEURO

Neuro-Oncology

3 Pathways
PED

Pediatric Oncology

4 Pathways
CLL

CLL/Lymphoma

5 Pathways

New pathways added regularly based on clinical developments and partner needs.

What Our Partners Say

Leading life sciences companies trust Dana-Farber Pathways for strategic insights.

The pathways data has transformed how we approach market access discussions. We now have clear evidence of where our therapies fit in expert-driven treatment protocols.
VP of Medical Affairs
Major Pharmaceutical Company

Beyond Traditional Real-World Data

Dana-Farber Pathways provides insights that traditional RWD sources cannot offer.

Feature
Traditional RWD
Dana-Farber Pathways
Treatment protocol visibility
Clinical rationale documentation
Expert committee insights
Real-time pathway updates
Drug placement context
Academic institution perspective
?

Why does rationale matter?

Understanding why treatments are recommended provides crucial context for market access discussions, clinical development planning, and competitive positioning. Dana-Farber Pathways bridges the gap between treatment data and clinical reasoning.

Access Information on the Go

Our mobile-friendly platform ensures you have critical pathway information at your fingertips, whether you're in the office, at a conference, or on the move.

Treatment Pathways on mobile

Treatment Pathways

Fully Responsive

Access pathways, drug information, and meeting notes from any device

Always Connected

Stay informed with real-time updates wherever you are

Quick Access

Get critical pathway information in seconds, not minutes

50+
Treatment Pathways
12
Disease Centers
200+
Drugs Tracked
10+
Enterprise Partners

Trusted by Leading Life Sciences Organizations

Partner Company 1
Partner Company 2
Partner Company 3
Partner Company 4
Partner Company 5

Dana-Farber Cancer Institute is a principal teaching affiliate of Harvard Medical School and a founding member of Dana-Farber/Harvard Cancer Center.

Enterprise Partnership Model

Dana-Farber Pathways is available through annual enterprise subscriptions, customized to meet your organization's specific needs and use cases.

Number of disease centers accessed
Meeting minutes access level
User seats and permissions
API access for integration
Custom reporting and analytics
Dedicated support and training
?

Ready to Learn More?

Schedule a personalized demo to see how Dana-Farber Pathways can support your organization's strategic objectives.

Typically respond within 1-2 business days

Request a Demo

See how Dana-Farber Pathways can provide strategic insights for your organization. Fill out the form and our team will be in touch shortly.

What to expect:

  • Personalized platform walkthrough
  • Discussion of your specific use cases
  • Answers to your questions
  • Custom pricing proposal

Questions? Contact us directly:

pathways@dfci.harvard.edu

Select disease centers...

By submitting this form, you agree to be contacted about Dana-Farber Pathways.